Genomic Consequences of Estrogen Receptor Activation in the Cervix
子宫颈雌激素受体激活的基因组后果
基本信息
- 批准号:9237148
- 负责人:
- 金额:$ 24.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-15 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAnimal ModelAnimalsBindingBinding SitesBioinformaticsBiological SciencesBiologyBiomechanicsBirthCaviaCell modelCellsCervicalCervical RipeningCervix UteriCoculture TechniquesCompetenceDataEP300 geneEnhancersEpithelial CellsEstradiolEstrogen Receptor alphaEstrogen Receptor betaEstrogen ReceptorsEstrogensEventExtracellular MatrixFunctional disorderGene ExpressionGene ProteinsGene TargetingGenesGenetic TranscriptionGenomicsGoalsHormonesHumanImmuneInduced LaborInfant MortalityInfiltrationInflammatory Response PathwayLaboratoriesLengthMMP11 geneMaintenanceMediatingMethodologyMifepristoneModelingMolecularMolecular AnalysisNuclearOutcomeOxytocinPathway interactionsPeptide HydrolasesPhysiologicalPhysiologyPlayPregnancyPremature BirthPremature LaborProgesteroneProgesterone ReceptorsPropertyProstaglandinsProteinsRNARNA Polymerase IIReceptor ActivationRefractoryRegulationResearchRoleSignal PathwaySignal TransductionStromal CellsSymptomsTestingTissuesVaginaWithdrawalWorkchemokinechromatin immunoprecipitationdeep sequencingexperienceglobal run on sequencinghistone modificationin vivomyometriumnext generation sequencingnovelpregnantprematureprogesterone receptor Aprogesterone receptor Bprogramsreceptor functionreproductivetranscription factortranscriptometreatment response
项目摘要
ABSTRACT
The single most effective predictor of preterm birth is the state of cervix upon presentation with
symptoms of preterm labor. The mechanisms underlying physiological cervical ripening at term
are largely unknown, and the causes of preterm cervical dilation are even more elusive. Our
laboratory, together with complementary expertise in genomic and molecular analysis, has
expanded its long-term strength in the biology and physiology of human parturition to include a
more integrated approach to delve deeply into the molecular transcriptional and genomic
mechanisms that underpin the physiology of normal labor at term and the pathophysiology of
preterm birth. Here, we propose (i) to determine if ER antagonists block preterm cervical
ripening and labor, (ii) to explore the global effects of PR- and ER-mediated signaling pathways
in human cervical epithelial and stromal cells and the cellular mechanisms by which PRs inhibit
ER-mediated signaling, and (iii) to determine the role of ER-mediated signaling pathways in
cervical ripening and dilation in vivo.
摘要
预测早产最有效的单一指标是宫颈状况。
早产的症状。足月生理性宫颈成熟的机制
在很大程度上是未知的,早产宫颈扩张的原因更是难以捉摸。我们的
实验室,加上基因组和分子分析方面的互补专业知识,已经
扩大了其在人类分娩生物学和生理学方面的长期实力,包括
深入研究分子转录和基因组的更完整的方法
足月正常分娩的生理学基础及其病理生理学机制
早产。在这里,我们建议:(I)确定雌激素受体拮抗剂是否阻断早产宫颈
成熟和分娩,(Ii)探索PR和ER介导的信号通路的全球效应
人宫颈上皮和间质细胞及其抑制PR的细胞机制
内质网介导的信号转导,以及(Iii)确定内质网介导的信号通路在
活体宫颈成熟和扩张。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUTH A WORD其他文献
RUTH A WORD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUTH A WORD', 18)}}的其他基金
Genomic Consequences of Estrogen Receptor Activation in the Cervix
子宫颈雌激素受体激活的基因组后果
- 批准号:
10063454 - 财政年份:2016
- 资助金额:
$ 24.3万 - 项目类别:
Human Tissue and Biological Fluid Acquisition Laboratory Core
人体组织和生物液体采集实验室核心
- 批准号:
10063451 - 财政年份:2016
- 资助金额:
$ 24.3万 - 项目类别:
Mechanisms of Prostaglandin-induced Cervical Ripening in Humans
前列腺素诱导人类宫颈成熟的机制
- 批准号:
9102219 - 财政年份:2015
- 资助金额:
$ 24.3万 - 项目类别:
Protease regulation and integrity of connective tissues of the pelvic floor
盆底结缔组织的蛋白酶调节和完整性
- 批准号:
8669737 - 财政年份:2010
- 资助金额:
$ 24.3万 - 项目类别:
Protease regulation and integrity of connective tissues of the pelvic floor
盆底结缔组织的蛋白酶调节和完整性
- 批准号:
8470671 - 财政年份:2010
- 资助金额:
$ 24.3万 - 项目类别:
Protease regulation and integrity of connective tissues of the pelvic floor
盆底结缔组织的蛋白酶调节和完整性
- 批准号:
8132380 - 财政年份:2010
- 资助金额:
$ 24.3万 - 项目类别:
Protease regulation and integrity of connective tissues of the pelvic floor
盆底结缔组织的蛋白酶调节和完整性
- 批准号:
8291898 - 财政年份:2010
- 资助金额:
$ 24.3万 - 项目类别:
Protease regulation and integrity of connective tissues of the pelvic floor
盆底结缔组织的蛋白酶调节和完整性
- 批准号:
7987297 - 财政年份:2010
- 资助金额:
$ 24.3万 - 项目类别:
Human Tissue Acquisition and Cell Culture Laboratory
人体组织采集和细胞培养实验室
- 批准号:
7750556 - 财政年份:2008
- 资助金额:
$ 24.3万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 24.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别: